Case study · Medtech · Ireland and the US · Ongoing
A medtech story investors and editors back.
SymPhysis Medical is a Galway medtech company developing releaze, a drainage system designed so patients with malignant pleural effusion can manage their care at home. We tell its story to investors, editors and the medtech community as it grows from Galway to Rhode Island.
verified pieces in six months, October 2025 to April 2026
national papers: The Irish Times, the Irish Independent and the Irish Examiner
US business titles in Rhode Island, Providence Business First and Providence Business News
pieces in national trade press, plus regional print in four titles
The challenge
Complex science, a fundraising clock.
A device still in development is hard to explain and harder to get written about. SymPhysis needed investors to understand it, and to act, while running an EIIS round and a public crowdfunding campaign at the same time.
What we did
Make the investment case human.
We positioned CEO Tim Jones as a voice on how Irish savers back Irish companies, wrote the investor communications for the crowdfunding round, built a social media advocacy programme for the board, and pointed the company towards the awards that would carry its name further.
Investors back people before they back products. So we put the people first.
The results
From Galway to the national pages.
Dec 2025
A new board appointment is covered in the Irish Examiner.
US base
SymPhysis announces its first US headquarters in Rhode Island, backed by a 1.25 million dollar award from the Rhode Island Life Science Hub.
May 2026
SymPhysis wins Emerging Technology Innovation of the Year at the TechCentral Tech Excellence Awards, an entry Bannerton put forward.
July 2026
Tim Jones is named MedTech Innovation Person of the Month.
Aug 2026
The Sunday Independent's feature on the EIIS tax relief names SymPhysis as its medtech case study, as the crowdfunding round opens.
releaze is in development and is not yet approved for use.
In pictures
Where SymPhysis was heard
